- Investing Ideas
- Norwegian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Norwegian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
2
0 new
Value score of at least 4 focused on companies with a low market cap.
2 companies
Navamedic
Market Cap: NOK 416.1m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 17.35
7D
-3.3%
1Y
-22.2%
Norda
Market Cap: NOK 443.4m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 86.40
7D
0%
1Y
n/a